Clinical Trials Browser

Phase 3 × INDUSTRY × Disease × Clear all

NCT07615101 2026-06-01

Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.

Phase 3 Not yet recruiting

Disease, Prostatic Neoplasms

NCT04186845 2025-09-22

Spotlight

Phase 3 Completed

391 enrolled 30 charts

Disease, Prostatic Neoplasms

NCT04410133 2025-08-28

REVELATE

Phase 3 Completed

151 enrolled 29 charts

Brain Neoplasms, Disease

NCT04186819 2025-02-26

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Phase 3 Completed

356 enrolled 28 charts

Disease, Prostatic Neoplasms

NCT03739684 2021-06-14

CONDOR

Phase 3 Completed

208 enrolled 10 charts

Disease, Prostatic Neoplasms

NCT03335059 2020-04-15

RITE-USA

Phase 3 Terminated

Urinary Bladder Neoplasms, Disease

NCT00126412 2019-05-31

Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

Phase 3 Completed

Disease, Neuroblastoma, Pheochromocytoma

NCT02615067 2019-04-10

proSPECT-AS

Phase 3 Completed

Disease, Prostatic Neoplasms

NCT01476774 2015-07-08

NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain

Phase 3 Completed

Disease